Sandu Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/07/2026 ,inter alia, to consider and approve 1. To place on record the demise of Shri Umesh B. Sandu(DIN:01132141), Managing Director of the Company, on 19th June, 2026, and to record the Board''s appreciation for his invaluable contribution to the Company.2. To consider and approve the appointment of a Managing Director of the Company pursuant to the demise of the erstwhile Managing Director, Late Shri Umesh B. Sandu, subject to the approval of the shareholders of the Company and such other statutory and regulatory approvals as may be required.3. To consider and approve the reconstitution of the Committees of the Board.4. To consider and approve the appointment of an Additional Director in the capacity of an Independent Director (Non-Executive) on the Board of the Company, subject to the approval of the shareholders of the Company and such other statutory and regulatory approvals, if any, as may be required.
Sandu Pharmaceuticals Limited Press Release Jul 06 2026
Filed with BSE · · 2 pages · English
Release
Sandu Pharmaceuticals Limited on 6ix
Earlier from Sandu Pharmaceuticals
- Sandu Pharmaceuticals Limited Press Release Jun 24 2026
- Sandu Pharmaceuticals Limited Press Release Jun 20 2026
- Sandu Pharmaceuticals Limited Press Release Jun 19 2026
- Sandu Pharmaceuticals Limited Press Release Jun 06 2026
- Sandu Pharmaceuticals Limited Press Release May 18 2026
Later from Sandu Pharmaceuticals
- Sandu Pharmaceuticals Limited Press Release Jul 07 2026
- Sandu Pharmaceuticals Limited Press Release Jul 08 2026
- Sandu Pharmaceuticals Limited Press Release Jul 11 2026
- Sandu Pharmaceuticals Limited Press Release Aug 03 2026
- Sandu Pharmaceuticals Limited Press Release Aug 13 2026
Follow Sandu Pharmaceuticals into a list and get an email when it puts out news.
Follow Sandu Pharmaceuticals